Pharmaceutical stocks have seen significant gains this year, with the iShares U.S. Pharmaceuticals ETF (NYSEMKT: IHE) up nearly 29% year to date. Investors should pay attention to AbbVie (NYSE: ABBV), a company specializing in treatments across various medical fields. AbbVie recently reported quarterly results that surpassed expectations, with sales reaching $15.78 billion, a 9.1% increase, and earnings of $1.86 per share, exceeding forecasts by 11 cents.
